Pink Sheet Podcast: Sharpless On Zolgensma, US FDA Leadership Changes And Appropriations
Executive Summary
Our take on acting US FDA Commissioner Norman Sharpless' thoughts on press coverage of the Zolgensma approval, the agency's chief of staff announcing her departure, and the House Appropriations Committee approving the FDA's fiscal year 2020 funding bill.